Nifty
Sensex
:
:
23587.50
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 524372 | NSE: ORCHPHARMA

1790.65
20-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  1840.25
  •  1841.10
  •  1770.60
  •  1829.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  61250
  •  1097.49
  •  1841.10
  •  692.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 9,084.05
  • 76.35
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 9,004.56
  • N/A
  • 7.42

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.84%
  • 1.52%
  • 7.59%
  • FII
  • DII
  • Others
  • 1.94%
  • 17.59%
  • 1.52%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -7.29
  • 11.11
  • 13.56

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -9.99
  • -
  • 15.21

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 38.03

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.39
  • 3.10
  • 3.29

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.71
  • 55.81
  • 32.15

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
19.06
27.03
37.73
66.86
P/E Ratio
83.04
58.56
41.95
23.67
Revenue
816
1035
1606
2346
EBITDA
111
163
244
534
Net Income
92
139
207
361
ROA
6.6
0.1
0.1
0.2
P/Bk Ratio
6.86
6.14
5.73
4.61
ROE
9.92
11.05
14.65
21.15
FCFF
56.82
-189.47
-440.44
156.48
FCFF Yield
0.73
-2.42
-5.62
2

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
222.70
198.75
12.05%
244.41
182.92
33.62%
217.10
209.90
3.43%
220.59
159.76
38.08%
Expenses
192.36
175.44
9.64%
211.91
160.78
31.80%
188.18
170.21
10.56%
185.20
146.10
26.76%
EBITDA
30.34
23.31
30.16%
32.49
22.14
46.75%
28.92
39.69
-27.14%
35.39
13.66
159.08%
EBIDTM
13.62%
11.73%
13.29%
12.10%
13.32%
18.91%
16.04%
8.55%
Other Income
7.52
8.36
-10.05%
7.57
1.89
300.53%
13.36
1.73
672.25%
7.62
8.93
-14.67%
Interest
3.33
3.80
-12.37%
3.50
5.54
-36.82%
3.47
7.48
-53.61%
3.54
7.68
-53.91%
Depreciation
8.63
7.84
10.08%
8.44
7.71
9.47%
8.42
7.21
16.78%
9.27
8.18
13.33%
PBT
25.90
20.02
29.37%
28.12
10.78
160.85%
30.38
65.93
-53.92%
30.19
6.73
348.59%
Tax
0.00
0.00
0
-0.15
0.00
-
-3.12
0.00
-
0.00
0.00
0
PAT
25.90
20.02
29.37%
28.27
10.78
162.24%
33.50
65.93
-49.19%
30.19
6.73
348.59%
PATM
11.63%
10.07%
11.57%
5.89%
15.43%
31.41%
13.69%
4.21%
EPS
5.37
3.90
37.69%
5.79
1.85
212.97%
6.50
14.49
-55.14%
5.80
1.86
211.83%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
904.80
819.37
665.90
559.56
450.06
483.80
599.98
682.98
796.50
873.44
1,746.61
Net Sales Growth
20.43%
23.05%
19.00%
24.33%
-6.97%
-19.36%
-12.15%
-14.25%
-8.81%
-49.99%
 
Cost Of Goods Sold
531.48
484.46
384.62
313.56
228.51
203.35
289.70
350.20
393.46
400.96
779.03
Gross Profit
373.32
334.91
281.28
246.00
221.56
280.45
310.28
332.79
403.05
472.47
967.58
GP Margin
41.26%
40.87%
42.24%
43.96%
49.23%
57.97%
51.72%
48.73%
50.60%
54.09%
55.40%
Total Expenditure
777.65
708.58
581.60
504.98
399.40
514.99
611.80
658.68
709.37
702.65
1,429.32
Power & Fuel Cost
-
62.92
61.26
52.74
39.31
47.44
48.76
50.69
54.33
55.28
102.19
% Of Sales
-
7.68%
9.20%
9.43%
8.73%
9.81%
8.13%
7.42%
6.82%
6.33%
5.85%
Employee Cost
-
69.64
65.35
63.28
67.11
74.86
82.28
86.22
80.25
86.81
193.82
% Of Sales
-
8.50%
9.81%
11.31%
14.91%
15.47%
13.71%
12.62%
10.08%
9.94%
11.10%
Manufacturing Exp.
-
39.75
35.55
32.88
29.10
53.25
55.98
65.65
87.40
94.33
182.40
% Of Sales
-
4.85%
5.34%
5.88%
6.47%
11.01%
9.33%
9.61%
10.97%
10.80%
10.44%
General & Admin Exp.
-
22.22
14.26
13.03
18.34
43.67
30.72
41.49
40.99
31.10
91.62
% Of Sales
-
2.71%
2.14%
2.33%
4.08%
9.03%
5.12%
6.07%
5.15%
3.56%
5.25%
Selling & Distn. Exp.
-
23.86
14.34
22.26
13.46
8.14
10.34
22.10
45.73
27.73
51.28
% Of Sales
-
2.91%
2.15%
3.98%
2.99%
1.68%
1.72%
3.24%
5.74%
3.17%
2.94%
Miscellaneous Exp.
-
5.73
6.22
7.22
3.59
84.27
94.02
42.34
7.21
6.44
51.28
% Of Sales
-
0.70%
0.93%
1.29%
0.80%
17.42%
15.67%
6.20%
0.91%
0.74%
1.66%
EBITDA
127.14
110.79
84.30
54.58
50.66
-31.19
-11.82
24.30
87.13
170.79
317.29
EBITDA Margin
14.05%
13.52%
12.66%
9.75%
11.26%
-6.45%
-1.97%
3.56%
10.94%
19.55%
18.17%
Other Income
36.07
31.13
19.43
9.00
15.21
24.28
16.93
20.30
19.17
24.91
42.47
Interest
13.84
16.74
32.90
33.46
52.21
6.23
6.69
310.26
331.11
294.24
537.12
Depreciation
34.76
33.24
54.79
87.02
108.92
117.93
129.94
133.31
141.02
145.27
324.58
PBT
114.59
91.95
16.04
-56.90
-95.25
-131.07
-131.52
-398.96
-365.82
-243.82
-501.95
Tax
-3.27
-3.12
0.00
0.00
0.00
0.00
0.00
-46.19
-48.04
-17.25
-191.46
Tax Rate
-2.85%
-3.39%
0.00%
0.00%
0.00%
0.00%
0.00%
11.58%
8.92%
5.82%
49.27%
PAT
117.86
95.06
55.25
-56.90
-95.25
-131.07
69.41
-352.77
-490.49
-279.11
-196.51
PAT before Minority Interest
117.86
95.06
55.25
-56.90
-95.25
-131.07
69.41
-352.77
-490.49
-279.11
-197.13
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.62
PAT Margin
13.03%
11.60%
8.30%
-10.17%
-21.16%
-27.09%
11.57%
-51.65%
-61.58%
-31.96%
-11.25%
PAT Growth
13.92%
72.05%
-
-
-
-
-
-
-
-
 
EPS
23.25
18.75
10.90
-11.22
-18.79
-25.85
13.69
-69.58
-96.74
-55.05
-38.76

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
1,169.47
688.65
647.38
652.91
765.98
-704.04
-791.76
-387.67
49.04
329.39
Share Capital
50.72
40.82
40.82
40.82
40.82
88.96
88.96
88.96
88.96
85.26
Total Reserves
1,118.75
647.83
606.56
612.09
725.17
-793.00
-880.72
-476.63
-39.92
244.12
Non-Current Liabilities
124.43
164.67
222.40
442.26
518.98
1,435.53
1,904.62
2,204.95
2,475.41
2,609.35
Secured Loans
0.22
40.09
110.84
341.60
429.50
1,424.61
1,893.91
2,156.78
2,377.54
2,493.95
Unsecured Loans
120.21
108.75
97.32
85.90
74.47
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
3.63
12.60
11.01
11.54
11.79
7.70
7.48
2.07
3.73
4.18
Current Liabilities
259.97
371.89
240.78
142.08
174.94
2,345.54
2,012.51
1,540.72
1,337.62
1,122.66
Trade Payables
229.58
174.37
167.68
109.95
101.59
302.45
358.79
424.52
374.27
311.15
Other Current Liabilities
14.27
53.09
47.25
25.76
70.10
1,343.97
958.40
476.24
285.34
112.64
Short Term Borrowings
14.05
140.95
22.84
2.84
0.00
695.49
694.29
599.52
633.79
646.64
Short Term Provisions
2.08
3.49
3.01
3.52
3.25
3.63
1.03
40.44
44.22
52.23
Total Liabilities
1,553.87
1,225.21
1,110.56
1,237.25
1,459.90
3,077.03
3,125.37
3,358.00
3,862.07
4,061.40
Net Block
620.23
573.09
583.70
670.45
857.93
1,256.26
1,386.20
1,496.54
1,636.83
1,795.20
Gross Block
1,300.94
1,220.56
1,176.39
1,176.10
1,247.11
1,519.52
1,519.16
3,005.92
3,005.87
3,002.15
Accumulated Depreciation
680.71
647.47
592.68
505.66
389.18
263.26
132.96
1,509.38
1,369.04
1,206.95
Non Current Assets
763.12
724.20
712.91
687.39
890.58
2,309.57
2,446.42
2,478.86
2,610.87
2,783.27
Capital Work in Progress
30.67
46.46
9.78
7.43
25.61
278.16
271.53
288.31
280.40
281.51
Non Current Investment
45.82
44.44
45.49
0.40
0.34
0.47
1.07
0.96
0.81
0.81
Long Term Loans & Adv.
66.38
60.20
73.93
9.10
6.70
764.84
777.64
685.17
680.83
681.63
Other Non Current Assets
0.02
0.00
0.01
0.01
0.00
9.84
9.98
7.88
12.00
24.12
Current Assets
790.75
501.01
384.36
549.86
569.32
767.46
678.94
879.14
1,251.20
1,278.12
Current Investments
0.00
0.00
0.00
15.02
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
264.23
228.74
172.66
152.89
141.69
169.77
193.74
211.25
241.85
251.93
Sundry Debtors
195.55
215.19
170.57
135.70
67.97
119.89
119.51
203.00
310.07
256.57
Cash & Bank
266.57
30.63
8.06
19.91
174.04
325.52
305.55
257.06
314.94
390.56
Other Current Assets
64.41
3.95
13.01
130.47
185.62
152.28
60.14
207.82
384.34
379.06
Short Term Loans & Adv.
57.39
22.50
20.07
95.87
164.05
140.27
40.31
198.36
267.62
273.26
Net Current Assets
530.78
129.12
143.58
407.78
394.39
-1,578.08
-1,333.57
-661.58
-86.42
155.46
Total Assets
1,553.87
1,225.21
1,097.27
1,237.25
1,459.90
3,077.03
3,125.36
3,358.00
3,862.07
4,061.39

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
125.99
18.34
92.47
23.59
80.80
12.02
9.18
317.01
212.20
-369.07
PBT
89.05
46.32
-1.95
-116.53
-131.07
69.41
-398.96
-452.28
-296.18
-243.29
Adjustment
44.15
51.38
36.77
172.15
139.57
57.34
453.49
582.11
490.19
1,006.39
Changes in Working Capital
-7.84
-79.06
59.57
-36.96
61.89
-110.44
-38.31
187.17
18.19
-669.27
Cash after chg. in Working capital
125.36
18.64
94.38
18.66
70.38
16.30
16.22
317.01
212.20
93.84
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.63
-0.30
-1.91
4.92
10.42
-4.28
-7.04
0.00
0.00
-47.03
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-415.87
Cash From Investing Activity
-312.03
-31.21
112.94
67.21
167.11
45.47
-28.06
-8.59
-1.46
1,333.66
Net Fixed Assets
-54.94
-80.50
-2.64
89.19
430.14
-6.63
1,485.46
-7.97
-2.38
848.92
Net Investments
-19.28
-1.11
-33.59
-15.08
0.13
124.30
-0.11
-0.01
0.00
-0.47
Others
-237.81
50.40
149.17
-6.90
-263.16
-72.20
-1,513.41
-0.61
0.92
485.21
Cash from Financing Activity
167.04
31.17
-216.80
-164.99
-250.33
-0.30
33.39
-366.30
-286.36
-597.44
Net Cash Inflow / Outflow
-19.00
18.29
-11.39
-74.20
-2.42
57.20
14.51
-57.88
-75.62
367.14
Opening Cash & Equivalents
22.60
4.31
15.69
89.89
92.31
35.11
20.60
314.94
390.56
23.42
Closing Cash & Equivalent
3.60
22.60
4.31
15.69
89.89
92.31
35.11
257.06
314.94
390.56

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
230.58
168.72
158.61
159.96
187.67
-79.14
-89.00
-43.58
5.51
38.63
ROA
6.84%
4.73%
-4.85%
-7.06%
-5.78%
2.24%
-10.88%
-13.59%
-7.05%
-4.53%
ROE
10.23%
8.27%
-8.75%
-13.43%
-423.17%
0.00%
0.00%
0.00%
-147.51%
-55.58%
ROCE
9.35%
9.11%
-2.32%
-3.53%
-6.47%
3.08%
-3.46%
-6.93%
-0.06%
4.17%
Fixed Asset Turnover
0.65
0.56
0.48
0.37
0.35
0.39
0.30
0.27
0.29
0.52
Receivable days
91.49
105.72
99.89
82.59
70.86
72.82
85.57
115.97
116.98
45.27
Inventory Days
109.80
110.01
106.18
119.45
117.49
110.57
107.46
102.41
101.94
78.79
Payable days
152.17
162.30
161.59
168.95
136.49
197.80
198.57
186.30
148.72
86.46
Cash Conversion Cycle
49.12
53.43
44.47
33.09
51.86
-14.40
-5.54
32.07
70.20
37.60
Total Debt/Equity
0.12
0.48
0.41
0.69
0.74
-4.59
-4.04
-8.01
65.54
9.75
Interest Cover
6.49
2.68
-0.70
-0.82
-20.04
11.38
-0.29
-0.63
-0.01
0.28

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.